Jump to content

Methylphenidate: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 May 2026

  • curprev 01:1001:10, 27 May 2026 Maintenance script talk contribs 17,862 bytes +6,935 parser-claude (pharmacist-claude hat): citation pass + content fills per Mark go 2026-05-26. Adds: history section (Panizzon 1944, Ciba launch, Schedule II 1971, MTA study, Cooper 2011 CV outcomes), Cortese 2018 NMA in intro, FDA warning refs (4), references/> infrastructure, FDA Ritalin label ref on PK, Ritalin IR indication clarification, MPH-TCA interaction revision, anecdote typo fix. [automatically checked]

23 May 2026

19 May 2026

17 May 2026

16 May 2026

14 May 2026

11 May 2026

  • curprev 08:1508:15, 11 May 2026 MDElliottMD talk contribs 11,011 bytes +11,011 Created page with "{{MedTemplate | generic = Methylphenidate | brand = Ritalin, Ritalin LA, Concerta, Metadate CD, Daytrana, Quillivant XR | structure = Methylphenidate.svg | classes = Psychostimulant, CNS stimulant, NDRI | mechanism = Norepinephrine–dopamine reuptake inhibition (DAT, NET) | uses = ADHD, narcolepsy | formula = C<sub>14</sub>H<sub>19</sub>NO<sub>2</sub> | routes = Oral, transdermal | onset..." Tag: 2017 source edit [automatically checked]